The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation
- PMID:9210483
- DOI: 10.1111/j.1432-1033.1997.t01-1-00193.x
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation
Abstract
The lantibiotic mersacidin has been previously reported to interfere with bacterial peptidoglycan biosynthesis, [Brötz, H., Bierbaum, G., Markus, A., Molitor, E. & Sahl, H.-G. (1995) Antimicrob. Agents Chemother. 39, 714-719]. Here, we focus on the target reaction and describe a mersacidin-induced accumulation of UDP-N-acetylmuramoyl-pentapeptide, indicating that inhibition of peptidoglycan synthesis occurs after the formation of cytoplasmic precursors. In vitro studies involving a wall-membrane particulate fraction of Bacillus megaterium KM demonstrated that mersacidin did not prevent the synthesis of lipid II [undecaprenyl-diphosphoryl-N-acetylmuramoyl-(pentapeptide)-N-ac ety lglucosamine] but specifically the subsequent conversion of this intermediate into polymeric nascent glycan strands by transglycosylation. Comparison with other inhibitors of transglycosylation shows that the effective concentration of mersacidin in vitro is in the range of that of the glycopeptide antibiotic vancomycin but 2-3 orders of magnitude higher than that of the competitive enzyme inhibitor moenomycin. The analogy to the glycopeptides may hint at an interaction of mersacidin with the peptidoglycan precursor rather than with the enzyme. Unlike vancomycin however, mersacidin inhibits peptidoglycan formation from UDP-N-acetylmuramoyl-tripeptide and is active against Enterococcus faecium expressing the vanA resistance gene cluster. This indicates that the molecular target site of mersacidin differs from that of vancomycin and that no cross-resistance exists between the two antibiotics.
Similar articles
- The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.Brötz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG.Brötz H, et al.Antimicrob Agents Chemother. 1998 Jan;42(1):154-60. doi: 10.1128/AAC.42.1.154.Antimicrob Agents Chemother. 1998.PMID:9449277Free PMC article.
- Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?Brötz H, Bierbaum G, Markus A, Molitor E, Sahl HG.Brötz H, et al.Antimicrob Agents Chemother. 1995 Mar;39(3):714-9. doi: 10.1128/AAC.39.3.714.Antimicrob Agents Chemother. 1995.PMID:7793878Free PMC article.
- Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.Allen NE, Hobbs JN Jr, Nicas TI.Allen NE, et al.Antimicrob Agents Chemother. 1996 Oct;40(10):2356-62. doi: 10.1128/AAC.40.10.2356.Antimicrob Agents Chemother. 1996.PMID:8891144Free PMC article.
- Antimicrobial mechanism of lantibiotics.Islam MR, Nagao J, Zendo T, Sonomoto K.Islam MR, et al.Biochem Soc Trans. 2012 Dec 1;40(6):1528-33. doi: 10.1042/BST20120190.Biochem Soc Trans. 2012.PMID:23176511Review.
- Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.Grein F, Schneider T, Sahl HG.Grein F, et al.J Mol Biol. 2019 Aug 23;431(18):3520-3530. doi: 10.1016/j.jmb.2019.05.014. Epub 2019 May 14.J Mol Biol. 2019.PMID:31100388Review.
Cited by
- The antimicrobial activity of protein elicitor AMEP412 against Streptomyces scabiei.Liu Q, Shen Y, Yin K.Liu Q, et al.World J Microbiol Biotechnol. 2020 Jan 7;36(1):18. doi: 10.1007/s11274-019-2794-7.World J Microbiol Biotechnol. 2020.PMID:31912374
- Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II.Varney KM, Bonvin AM, Pazgier M, Malin J, Yu W, Ateh E, Oashi T, Lu W, Huang J, Diepeveen-de Buin M, Bryant J, Breukink E, Mackerell AD Jr, de Leeuw EP.Varney KM, et al.PLoS Pathog. 2013;9(11):e1003732. doi: 10.1371/journal.ppat.1003732. Epub 2013 Nov 7.PLoS Pathog. 2013.PMID:24244161Free PMC article.
- Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.Szekat C, Jack RW, Skutlarek D, Färber H, Bierbaum G.Szekat C, et al.Appl Environ Microbiol. 2003 Jul;69(7):3777-83. doi: 10.1128/AEM.69.7.3777-3783.2003.Appl Environ Microbiol. 2003.PMID:12839744Free PMC article.
- Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance.Kramer NE, van Hijum SA, Knol J, Kok J, Kuipers OP.Kramer NE, et al.Antimicrob Agents Chemother. 2006 May;50(5):1753-61. doi: 10.1128/AAC.50.5.1753-1761.2006.Antimicrob Agents Chemother. 2006.PMID:16641446Free PMC article.
- The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.Brötz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG.Brötz H, et al.Antimicrob Agents Chemother. 1998 Jan;42(1):154-60. doi: 10.1128/AAC.42.1.154.Antimicrob Agents Chemother. 1998.PMID:9449277Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical